SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets [version 1; peer review: 1 approved, 2 approved with reservations]
Background: Severe coronavirus disease 2019 (COVID-19) is associated with multiple comorbidities and is characterized by an auto-aggressive inflammatory state leading to massive collateral damage. To identify preventive and therapeutic strategies against severe acute respiratory syndrome coronavirus...
Main Authors: | Gianmarco Bellucci, Chiara Ballerini, Rosella Mechelli, Rachele Bigi, Virginia Rinaldi, Roberta Reniè, Maria Chiara Buscarinu, Sergio E. Baranzini, Lohith Madireddy, Giuseppe Matarese, Marco Salvetti, Giovanni Ristori |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2020-08-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/9-992/v1 |
Similar Items
-
Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?
by: Gianmarco Bellucci, et al.
Published: (2021-09-01) -
A Case of Double Standard: Sex Differences in Multiple Sclerosis Risk Factors
by: Benedetta Angeloni, et al.
Published: (2021-04-01) -
MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune Diseases
by: Rosella Mechelli, et al.
Published: (2021-05-01) -
Reworking GWAS Data to Understand the Role of Nongenetic Factors in MS Etiopathogenesis
by: Rosella Mechelli, et al.
Published: (2020-01-01) -
RNA interactomics: recent advances and remaining challenges [version 1; referees: 2 approved]
by: Brigitte Schönberger, et al.
Published: (2018-11-01)